Research compound guide
Buy Retatrutide Research Compound.
Retatrutide is a next-generation triple receptor agonist targeting GLP-1, GIP, and glucagon receptors — making it one of the most studied metabolic peptides in preclinical research. This guide covers sourcing retatrutide for research with documented quality standards.
What is retatrutide?
Retatrutide (LY3437943) is a synthetic peptide that acts as a triple agonist at three metabolic receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This triple mechanism distinguishes it from both semaglutide (GLP-1 only) and tirzepatide (GLP-1 + GIP). The addition of glucagon receptor agonism introduces lipolytic and thermogenic effects that are the focus of active research.
Retatrutide supplied by B&H Bio is a research compound for laboratory evaluation only. It is not for human consumption.
Retatrutide specifications
| Specification | Standard | Why it matters |
|---|---|---|
| Molecular formula | C₂₂₁H₃₃₉N₅₇O₇₆ | Confirms molecular identity |
| Molecular weight | ~4,924.6 g/mol | For molar concentration calculations |
| Purity | ≥ 99% (HPLC) | Ensures research reproducibility |
| Form | Lyophilized powder | Stable for storage and shipping |
| Mechanism | Triple GLP-1/GIP/glucagon receptor agonist | Unique triple mechanism |
| Appearance | White to off-white powder | Visual quality indicator |
Retatrutide vs tirzepatide vs semaglutide
| Parameter | Retatrutide | Tirzepatide | Semaglutide |
|---|---|---|---|
| Receptor targets | GLP-1 + GIP + Glucagon (triple) | GLP-1 + GIP (dual) | GLP-1 (selective) |
| Molecular weight | ~4,924.6 g/mol | ~4,813.52 g/mol | ~4,113.58 g/mol |
| Glucagon activity | Yes | No | No |
| Lipolysis research | Direct glucagon-mediated | Indirect | Indirect |
| Thermogenic effects | Research-supported | Limited | Limited |
How to evaluate retatrutide quality
- HPLC purity ≥ 99%Quantified purity percentage by HPLC — research conclusions depend on high-purity material, especially for triple receptor studies where impurities could confound receptor selectivity data.
- Mass spectrometry confirmationMS verifies the molecular weight (~4,924.6 g/mol), confirming correct synthesis of this complex 39-amino-acid peptide with its C20 fatty acid modification.
- Endotoxin testingLAL assay results must be reported for any in vitro or in vivo research application.
- Lot traceabilityEach batch linked to its COA via unique lot number for reproducibility.
Retatrutide storage and handling
-20°C storage
Store at -20°C in sealed, light-protected vials. Stable for 24+ months under proper conditions.
2-8°C storage
After reconstitution with bacteriostatic water, store at 2-8°C. Use within supplier-recommended timeframe.
Protect from light
Store in amber or foil-wrapped vials. Minimize light exposure during handling.
Retatrutide research applications
- Triple receptor pharmacologyStudies comparing GLP-1, GIP, and glucagon receptor signaling — unique to retatrutide's triple mechanism.
- Metabolic researchGlucose homeostasis, insulin secretion, and metabolic rate studies with glucagon-mediated lipolysis.
- Body compositionEffects on fat mass reduction, lean mass preservation, and energy expenditure.
- Lipid metabolismDirect glucagon receptor agonism enables lipolysis research not possible with GLP-1-only agonists.
- ThermogenesisGlucagon receptor activation and brown adipose tissue research.
- Comparative pharmacologyHead-to-head studies with semaglutide and tirzepatide across receptor panels.
Why choose B&H Bio for retatrutide
- Batch-linked documentationEvery retatrutide lot has linked quality records available for professional review.
- Lot traceabilityUnique identifiers reconcile each batch with its documentation.
- Research-use-only complianceClear RUO labeling with no therapeutic claims.
Ready to evaluate?
Request retatrutide documentation.
Match your research needs to current-batch quality records.